RT Journal Article
SR Electronic
T1 The Mediterranean Diet Scale (MDS): translation and validation of the Arabic version
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.06.08.23291163
DO 10.1101/2023.06.08.23291163
A1 Aljehani, Raghdah
A1 Aljehani, Ghaidaa
A1 Alharazi, Hanaa
A1 Horta, Paula M
A1 Duarte, Camila Kümmel
A1 Ghisi., Gabriela Lima de Melo
YR 2023
UL http://medrxiv.org/content/early/2023/06/12/2023.06.08.23291163.abstract
AB Objectives The self-administered version of the Mediterranean Diet Scale (MDS) has been developed to test the inherent characteristics of this dietary pattern in a quick and simple way, due to the need of this assessment in the clinical and research setting. This study aimed to translate and psychometrically validate the self-administered MDS in Arabic (CRBS-A).Methods The original (English) version was originally translated to Arabic, followed by back-translation. Next, 10 healthcare providers, followed by 10 cardiovascular disease (CVD) patients rated the face and content validity (CV) of materials, providing input to improve cross-cultural applicability. Then, 200 patients from Saudi Arabia completed the questionnaire, of which factor structure, internal consistency, criterion and construct validity were assessed.Results Content and face validity was supported based on experts and patients’ reviews (ranges: CV scores 0.9-1.0/1.0 and clarity 3.5 to 4.5/5). Minor edits were made. Subsequent factor analysis revealed 4 factors consistent with the original version of the instrument, all internally consistent. Total CRBS-A α was 0.74. Criterion validity was confirmed by the significantly higher scores in patients who participated in CR. Construct validity was also established by significant associations between MDS scores and monthly family income, having the diagnosis of acute coronary syndrome or with a history of valve repair or replacement, being obese or having dyslipidemia.Conclusions Overall, these results confirm the validity and reliability of the MDS in Arabic-speaking patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the King Abdullah Medical City Ethics Board, Saudi Arabia (22-944).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData cannot be shared publicly because of Ethics Restrictions. Data are available from the King Abdullah Medical City Institutional Data Access / Ethics Committee (contact via 1st author) for researchers who meet the criteria for access to confidential data.